MD Biosciences new release

News & Events

Wednesday, Jun 16, 2010 MD Biosciences
Wednesday, June 16, 2010, St. Paul, MN - MD Biosciences, a Preclinical Contract Research Organization (CRO), offers in vivo models for the study of myocardial infarct (MI). The occlusion-induced myocardial infarct model is a well-known...Read More
Tuesday, Oct 6, 2009 MD Biosciences
MD Biosciences (MDB) launches MD Bioproducts, a division of MD Biosciences, in a continued effort to meet client needs for high quality research products. The new division allows MD Biosciences to strengthen and expand it's product offering for...Read More
Monday, Oct 5, 2009 Amy Clausen
MD Biosciences (MDB), a contract research organization offering pre-clinical services and products in support of drug discovery for inflammatory and neurological diseases, relocated its U.S. office from 1000 Westgate Dr, St Paul, MN to 2575...Read More
Monday, Jul 6, 2009 Amy Clausen
MD Biosciences, a global biotechnology company, announces the recent launch of its new Tamm-Horsfall (THP, Uromodulin) ELISA. To date, very few manufactured ELISAs are commercially available for the measurement of THP, causing researchers to spend...Read More
Monday, Mar 16, 2009 Amy Clausen
Zurich, Switzerland Ottawa, Canada, March 16, 2009 – PharmaGap Inc. (TSX-V: GAP) (“PharmaGap” or “the Company”) and MD Biosciences GmbH (“MD Biosciences”) have entered into a co-development collaboration pertaining to novel compounds...Read More

Interesting Fact

Multiple Sclerosis is a lifelong ailment that affects more than 400,000 Americans, resulting in an earning loss of about $10.6 billion annually for U.S. families with MS.

Client Testimonial

“Among all the CROs that I have used over the years, including recently for inflammation, MD Biosciences has been one of the very best in terms of scientific knowledge, expertise, data quality, timelines, flexibility and personal contacts.”

O.B., Director of Preclinical Research Pharmaceutical Company